Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 857-874
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.857
Table 2 Univariable and Multivariable logistic regression for upstaging in the training set
VariablesVETC- (n = 53)VETC+ (n = 53)Univariate analysis
Multivariate analysis
OR
P value
OR
P value
Age, median (IQR)63 (50, 67)55 (51, 62)0.9970.096
Sex (%)1.3440.637
Male40 (75)43 (81)
Female13 (25)10 (19)
Hepatitis (%)1.1330.74
HBV or/and HCV47 (89)49 (92)
Negative6 (11)4 (8)
Cirrhosis (%)0.6690.626
Present44 (83)41 (77)
Absent9 (17)12 (23)
ALT, median (IQR)23 (15, 38)36 (20, 52)1.0100.0111.0010.738
AST, median (IQR)29 (21, 50)40 (28, 68)0.9890.0220.9910.450
GGT, median (IQR)39 (27, 87)100 (40, 185)1.0000.0011.0000.209
AFP, median (IQR)62.23 (5.48, 446.4)78.51 (8.05, 8213)0.9990.076
Main tumor size, median (IQR)4.1 (2.4, 6.5)8.9 (5.6, 10.8)2.815< 0.0011.873< 0.001
Multiplicity (%)0.7990.0090.9070.660
≥ 28 (15)21 (40)
145 (85)32 (60)
Single lobe involvement (%)0.620< 0.0010.9520.617
Present46 (87)28 (53)
Absent7 (13)25 (47)
Intratumor hemorrhage (%)0.6091
Present4 (8)5 (9)
Absent49 (92)48 (91)
Intratumor necrosis (%)0.850< 0.0017.947< 0.001
Present13 (25)44 (83)
Absent40 (75)9 (17)
Arterial phase hyperenhancement (%)1.1120.363
Present49 (92)52 (98)
Absent4 (8)1 (2)
Well defined capsule (%)1.0181
Present38 (72)37 (70)
Absent15 (28)16 (30)
Washout (%)1.8151
Present52 (98)53 (100)
Absent1 (2)0 (0)
Non-smooth tumor margin (%)1.7170.0141.1090.881
Present28 (53)41 (77)
Absent25 (47)12 (23)